Virogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetes - Enzolytics (OTC:ENZC)
Progress on Sagaliam Acquisition Corp TransactionALLEN, TX / ACCESSWIRE / August 4, 2023 / Enzolytics, Inc. (OTC:ENZC) (https://enzolytics.com/).Virogentics, Inc. ("VIRO"), a wholly owned subsidiary of